• Bangalore
  • 5 February 2013
  • News
  • By Narayan

Dr Bernstein: India should increase its visibility

India has the best opportunity in biotechnology if it follows important factors like pre-competitiveness, where pooling of resources is necessary to understand diseases and this is made possible only by industry-academia collaboration

web-image

Dr Karen Bernstein, co-founder and chairman, BioCentury, USA, speaking at a session on Bangalore India Bio

"India fits in perfectly as a global biotech hub provided it can increase generic medicine for both internal and other emerging markets, high level of differentiation, chart a clear path to early exit, bring-in capital efficiency especially in venture level, develop professional, nimble and entrepreneurial management of companies," said Dr Karen Bernstein, co-founder and chairman, BioCentury, USA.

Speaking at a session on how India can leverage the biotech industry and the challenges for India in this sector at the Bangalore India Bio 2013 organized by the Department of Information Technology, Bio-Technology and Science and Technology, Government of Karnataka on February 4, 2013, Dr Karen Bernstein, said, "India has the best opportunity in biotechnology if it follows important factors like - pre-competitiveness where pooling of resources is necessary to understand diseases and this is only possible by industry-academic collaboration. There exists major gaps in basic sciences that are key to enabling innovations in novel therapeutics. Improving productivity through collaboration is needed. The key to success lies in focusing and addressing specific areas of science."

She further said, "In India, the problem is about misalignment of time line. The solution for this is differentiating single project companies from therapeutic platform companies and a novel corporate structure. In future, the biotech R&D will be globalized in multiple tracks, more presumptive collaborations will take place, system will be driven by patients, and the need to adopt to world austerity."

Leave a Reply Sign in

Notify me of follow-up comments via e-mail address

Post Comment

BusinessWire India.com - Healthcare & biotechnology

Bwi-logo

L V Prasad Eye Institute at Bhubaneswar is Now Shri Mithu Tulsi Chanrai

Monday, 16 Jan 2017   |   L V Prasad Eye Institute (LVPEI)

Business Wire IndiaL V Prasad Eye Institute (LVPEI), Bhubaneswar celebrated its eleventh anniversary

Expo 2020 Dubai Launches Expo Live: an Innovation and Partnership Programme

Monday, 16 Jan 2017   |   Expo 2020 Dubai

Business Wire India Expo 2020 Dubai delivered the first public roll-out of its USD 100 million Expo Live

Matrix Launches PowerWatch X, Wins CES's Last Gadget Standing

Friday, 13 Jan 2017   |   Matrix Industries

Business Wire India Matrix Industries first unveiled the Matrix PowerWatch, a thermoelectric-powered

BusinessWire India.com - Pharmaceutical

Bwi-logo

L V Prasad Eye Institute at Bhubaneswar is Now Shri Mithu Tulsi Chanrai

Monday, 16 Jan 2017   |   L V Prasad Eye Institute (LVPEI)

Business Wire IndiaL V Prasad Eye Institute (LVPEI), Bhubaneswar celebrated its eleventh anniversary

BusinessWire India.com - Medical Devices

Bwi-logo

L V Prasad Eye Institute at Bhubaneswar is Now Shri Mithu Tulsi Chanrai

Monday, 16 Jan 2017   |   L V Prasad Eye Institute (LVPEI)

Business Wire IndiaL V Prasad Eye Institute (LVPEI), Bhubaneswar celebrated its eleventh anniversary

Survey Box

GST

GST: Boon or Bane for Healthcare?

Send this article by email

X